Landmark 6,000-Patient RCT Investigates AI-Assisted Endoscopy for H. pylori Detection and Premalignant Gastric Lesion Identification — Gastric Cancer Mortality as Primary Endpoint
247 Health News Editorial
·9 July 2026
·4 min read
·clinical-trialsA landmark 6,000-patient randomised trial from National Taiwan University Hospital is evaluating whether AI-assisted upper endoscopy can reduce gastric cancer-specific mortality by improving detection of H. pylori infection and premalignant gastric lesions. With a primary endpoint of gastric cancer-related death and an estimated completion date of December 2028, this is among the most ambitious trials yet to test AI endoscopy against a hard clinical outcome. Gastroenterologists worldwide, including those managing high-risk populations in Australia, should follow this trial closely.
Originally reported by ClinicalTrials.gov
References
- 1.National Taiwan University Hospital. (2023). Application of artificial intelligence on the diagnosis of Helicobacter pylori infection and premalignant gastric lesion: A randomized clinical trial (NCT05762991). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT05762991
- 2.Plummer, M., Franceschi, S., Vignat, J., Forman, D., & de Martel, C. (2015). Global burden of gastric cancer attributable to Helicobacter pylori. International Journal of Cancer, 136(2), 487–490. https://doi.org/10.1002/ijc.29343
- 3.Dinis-Ribeiro, M., Areia, M., de Vries, A. C., Marcos-Pinto, R., Monteiro-Soares, M., O'Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., Dumonceau, J. M., Machado, J. C., Macedo, G., Malfertheiner, P., Matysiak-Budnik, T., Megraud, F., Miki, K., O'Morain, C., Peek, R. M., … Carneiro, F. (2012). Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy, 44(1), 74–94. https://doi.org/10.1055/s-0031-1291491
- 4.Lui, T. K. L., Tsui, V. W. M., & Leung, W. K. (2020). Accuracy of artificial intelligence-assisted detection of upper GI lesions: A systematic review and meta-analysis. Gastrointestinal Endoscopy, 92(4), 821–830.e9. https://doi.org/10.1016/j.gie.2020.06.034
- 5.Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
- 6.Correa, P. (1992). Human gastric carcinogenesis: A multistep and multifactorial process — First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Research, 52(24), 6735–6740. https://pubmed.ncbi.nlm.nih.gov/1458460/
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service